TABLE 1.
Patient | Age (y) | Injected dose (MBq) | Mass (μg) | ER/PR/HER2 | Tumor T/N | Tumor SUV | DVR |
---|---|---|---|---|---|---|---|
Dynamic patients | |||||||
1 | 59 | 359 | 5.38 | −/−/−/ | 1.9 | 3.4 | 2.4 |
2 | 39 | 281 | 0.84 | +/+/−/, +/+/−/* | 2.3, 2.5* | 3.0, 3.2* | 1.9, 2.7 |
3 | 59 | 222 | 3.41 | −/−/−/ | 1.9 | 1.5 | 1.4 |
4 | 32 | 178 | 0.83 | +/−/−/ | 1.1 | 3.9 | 1.4 |
5 | 57 | 366 | 0.53 | +/+/−/, +/+/−/* | 3.5, 2.8* | 3.4, 2.7* | 3.7, 2.8 |
6 | 58 | 148 | 1.91 | +/+/−/ | 1.2 | 2.1 | 1.1 |
7 | 71 | 366 | 0.56 | +/+/−/ | 2.2 | 2.9 | 2.0 |
8 | 58 | 370 | 0.34 | +/+/−/ | 1.7 | 1.2 | 1.6 |
Dosimetry patients | |||||||
1 | 49 | 89 | 1.39 | +/+/−/ | 2.4 | 1.2 | Not applicable |
2 | 52 | 185 | 1.87 | +/+/−/ | 1.9 | 2.3 | Not applicable |
3 | 64 | 370 | 2.67 | +/+/−/ | 1.8 | 2.4 | Not applicable |
4 | 49 | 104 | 0.83 | −/−/−/ | 1.5 | 1.6 | Not applicable |
5 | 53 | 329 | 0.75 | −/−/−/ | 1.5 | 1.2 | Not applicable |
6 | 47 | 270 | 1.32 | −/−/−/ | 1.2 | 0.5 | Not applicable |
7 | 68 | 359 | 0.90 | +/+/−/ | 1.5 | 1.2 | Not applicable |
8 | 64 | 370 | 0.31 | +/+/−/ | 4.0 | 4.4 | Not applicable |
9 | 44 | 215 | 0.90 | +/+/−/ | 2.6 | 1.8 | Not applicable |
10 | 62 | 352 | 0.54 | +/+/−/ | 4.0 | 3.2 | Not applicable |
11 | 55 | 315 | 0.76 | +/+/−/ | 3.2 | 1.9 | Not applicable |
12 | 49 | 259 | 0.70 | +/+/−/ | 3.8 | 2.3 | Not applicable |
Second breast cancer in patients with 2 breast cancers.